Digital Biomarker
Request Sample Report
Digital Biomarker Market Size and Growth
The Digital Biomarker market is experiencing significant growth, driven by advancements in technology and increased demand for remote health monitoring. The global market size is projected to reach approximately $2.5 billion by 2024, with a CAGR of around 30%, reflecting rising investment in healthcare digitalization and personalized medicine solutions.
Companies Covered
(Covid 19 Impact Covered)
◍ Philips
◍ Johnson & Johnson
◍ Pfizer
◍ GE Healthcare
◍ Novartis
◍ Apple
◍ Sanofi
◍ GlaxoSmithKline
◍ Bayer
◍ Merck
◍ Abbott Laboratories
◍ Asahi Kasei
◍ Biogen
◍ Koneksa Health
◍ Roche
◍ Huma Therapeutics
The Digital Biomarker Market features key players like Philips, Johnson & Johnson, and Pfizer, leveraging technology for remote patient monitoring and data analytics. These companies drive market growth by integrating digital health solutions into research and care, enhancing patient outcomes, and advancing precision medicine. Specific revenue figures are proprietary.
Request Sample Report
Market Segmentation
By Application
Clinical Disease
Daily Health
Request Sample Report
By Product
Passive Digital Biomarker
Active Digital Biomarker
$ 26110.00 Million
Request Sample Report
